HUTCHMED Highlights Data for AACR Annual Meeting

Biotech company to present research findings at major cancer conference

Apr. 9, 2026 at 3:48am

Got story updates? Submit your updates here. ›

A ghostly, translucent X-ray-style image revealing the intricate internal structure of a biological network or molecular system, conveying the scientific complexity and potential breakthroughs in cancer research.HUTCHMED's cancer research data to be presented at the AACR Annual Meeting showcases the company's commitment to advancing innovative therapies through rigorous scientific investigation.Florham Park Today

HUTCHMED, a global biopharmaceutical company, has announced that it will be presenting data from several of its clinical development programs at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026. The conference, one of the premier oncology research events, will take place in Florham Park, New Jersey.

Why it matters

HUTCHMED's participation in the AACR Annual Meeting underscores its commitment to advancing innovative cancer therapies through rigorous scientific research. The data presentations will provide the oncology community with insights into the company's pipeline and potential new treatment approaches.

The details

HUTCHMED will be showcasing data from multiple clinical trials evaluating its investigational cancer medicines. The presentations will cover a range of tumor types and therapeutic mechanisms, reflecting the breadth of the company's oncology portfolio.

  • The AACR Annual Meeting 2026 will take place from April 18-22, 2026.

The players

HUTCHMED

A global biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases.

Got photos? Submit your photos here. ›

What’s next

Following the AACR Annual Meeting, HUTCHMED will continue to advance its clinical development programs and work towards regulatory approvals for its investigational cancer medicines.

The takeaway

HUTCHMED's participation in the prestigious AACR Annual Meeting underscores its position as a leading innovator in the oncology field, as the company continues to make progress in developing new treatment options for patients with cancer.